Qube Research & Technologies (QRT)
NYMX

Qube Research & Technologies (QRT)’s Nymox Pharmaceutical Corp NYMX Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio NYMX Stock Details NYMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-66,800
Closed -$156K – 2067
2020
Q1 		$156K Hold
66,800
– – 0.01% 915
2019
Q4 		$147K Buy
+66,800
New +$132K ﹤0.01% 1430

Other funds holding NYMX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
SO
STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Qube Research & Technologies (QRT)'s NYMX Position: Q2 2020 in Review

Qube Research & Technologies (QRT) sold out of Nymox Pharmaceutical Corp (NYMX) in Q2 2020, closing a stake of 66,800 shares — an estimated $156K sold.

Qube Research & Technologies (QRT) first reported a position in NYMX in Q4 2019 and held it in 2 quarters. The position peaked at $156K in Q1 2020. 63 funds tracked by Wall St. Rank hold NYMX as of Q2 2020.

  • Qube Research & Technologies (QRT) reported no remaining Nymox Pharmaceutical Corp position as of Q2 2020 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 66,800 Nymox Pharmaceutical Corp shares in Q2 2020, an estimated $156K.
  • Qube Research & Technologies (QRT) first reported a position in Nymox Pharmaceutical Corp in Q4 2019 and held it in 2 quarters.
  • Qube Research & Technologies (QRT)'s Nymox Pharmaceutical Corp position peaked at $156K in Q1 2020.
  • 63 funds tracked by Wall St. Rank held Nymox Pharmaceutical Corp as of Q2 2020.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2020, filed 14 Aug 2020.